Read + Share
Alt M, Stecca C, Lin Y, Kazeem G, et al. Identification of characteristics predictive of long-term survival with
durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma. BMC Cancer 2023;23:919.
PMID: 37773115
|
 |
|
Alt M, Stecca C, Lin Y, Kazeem G, et al. Identification of characteristics predictive of long-term survival with
durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma. BMC Cancer 2023;23:919.
PMID: 37773115
|
|
|
|